Reagents are required to perform blood testing for BMT mission.
Ended Awarded Last action
- Contract number
- HT009026FG1230026
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,659
Award facts
- Contract value 100% obligated
- $49,658.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $49,658.82 to Phadia US Inc.'s Immunodiagnostics Division on December 10, 2025, for the supply of reagents required to perform blood testing in support of the bone marrow transplant (BMT) mission. The contract is structured as a firm fixed-price procurement with an ultimate completion date of September 30, 2026, and will be performed in Portage, Michigan. No set-aside designation was utilized in this award, reflecting an open market procurement process. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, is an established provider of advanced immunodiagnostic testing solutions to federal defense and healthcare agencies.
This BPA call represents continued engagement with Phadia US Inc., which has consistently supported military medical facilities through specialized diagnostic equipment and reagent supplies. The company maintains significant federal contract vehicles, including two single-award IDIQs valued at $13.8 million each with the Air Force Air Education and Training Command, which provide IMMUNOCAP analyzer systems and related support services to military medical facilities. The reagent procurement under this current award directly supports critical diagnostic capabilities for BMT patients within the Defense Health Agency's medical infrastructure, aligning with the agency's broader mission to deliver advanced healthcare services to the military beneficiary population.
Quick answers
Who was awarded contract HT009026FG1230026?
HT009026FG1230026 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on December 10, 2025.
How much is contract HT009026FG1230026 worth?
The government has obligated $49,659 on HT009026FG1230026.
Is contract HT009026FG1230026 an order under another contract?
Yes. HT009026FG1230026 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009026FG1230026 competed?
The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award